
Will Genetic Testing Help Diagnose Your Endometriosis Soon?
What new “risk signatures” really mean for you—and what they don’t

If you’ve spent years being told your pain is “normal,” it’s completely understandable to wish for a simple test that finally validates what you’re living with. Many people with endometriosis hope genetics will deliver that: a blood test, a cheek swab. Something! Anything! .... that shortens the 7–9 year diagnosis delay and gets you to treatment faster.
New genetic research is moving in that direction—but it’s not there yet. The most important takeaway is this: endometriosis risk appears to come from many small genetic factors that add up, not one or two “endometriosis genes.” That helps explain why diagnosis is still so hard and why treatments don’t work the same way for everyone. It also suggests where future therapies might come from—which is likely to be markedly different from what is recommended for treatment today.
What this kind of genetic research is
Traditional genetic studies often look for single genetic variants (single “spelling changes” in DNA) that are more common in people with endometriosis than people without it. Those single-variant signals are real, but they only explain a small slice of overall risk.
This newer approach looks for combinations of variants—small sets of 2–5 variants that tend to appear together more often in people with endometriosis. You can think of these as genetic “risk signatures.” The goal isn’t to say, “You have this signature, so you definitely have endometriosis.” It’s to see whether patterns of DNA differences point to biological processes that matter (like inflammation, scarring/fibrosis, nerve pain) and whether, one day, those patterns could help tailor treatments.
Does this mean a genetic test can diagnose endometriosis now?
Not based on the evidence we have.
In the research paper we reviewed, one specific two-variant signature showed a statistically significant association in an independent cohort, with an odds ratio around 1.21. That number may matter: but it’s a very small effect. Even if the association is real, it’s not strong enough to function as a stand-alone diagnostic test.
More broadly, most of the proposed signatures did not individually “replicate” with strong statistical certainty in the second dataset when correcting for the huge number of tests. Instead, the authors’ main argument is about directional consistency: across many signatures, more pointed toward higher risk in the second group than you’d expect by chance, especially for signatures that were relatively common.
What that means for you
- A DNA result would not be a yes/no answer for endometriosis right now.
- A “higher genetic risk” result would not replace imaging, symptoms, exam, or surgical diagnosis.
- A “lower genetic risk” result would not rule out disease—especially if your symptoms fit.
If you’re being dismissed today, a genetic test for these known variants is unlikely to be the validation tool you’re hoping for yet. Your symptoms, function, and treatment response still matter most in clinical care.
Could this eventually improve treatment (even if it doesn’t diagnose)?
Potentially—this is the more hopeful, practical angle.
Where genetic work can help patients over time is by pointing researchers toward the biology that drives symptoms in subgroups of patients. This paper highlights pathways that map onto things many of you recognize from lived experience:
- Fibrosis/scarring (which can contribute to pulling sensations, organ “stuck” pain, bowel/bladder symptoms, and pain with movement or sex)
- Neuropathic pain pathways (which may relate to burning, shooting pain, hypersensitivity, and pain that persists even after lesions are treated)
- Immune and inflammatory biology (including macrophage-related signals)
- Autophagy-related biology (a cellular “recycling”/stress-response process that, if altered, could influence inflammation and tissue behavior)
None of that gives you a new prescription today. But it supports a reality many patients already live: endometriosis is not one uniform disease experience, and future therapies may work better when matched to the dominant driver of your symptoms (inflammation vs fibrosis vs nerve sensitization, etc.). “It is a major gas-lighting fallacy that endometriosis is just one disease,” says Dr. Steven Vasilev, who guided the review of this peer-reviewed scientific publication. “It appears far more likely that endometriosis is a collection of similar diseases under a general symptom umbrella, with very different genetic and molecular drivers,” says Dr. Vasilev. “This would help explain why surgery or hormonal manipulation may work better, with more lasting results, in some patients over others,” he adds.
Explore Genetic Testing Options Today
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your TestA crucial caveat if you also have adenomyosis
This study’s endometriosis definition in the UK dataset explicitly excluded adenomyosis codes. So if you have adenomyosis (with or without endometriosis), you should be cautious about assuming these genetic “signatures” apply to your situation.
That doesn’t mean adenomyosis has no genetic component. It means this particular set of findings can’t be confidently generalized to adenomyosis based on the way the data were defined.
If you’re considering direct-to-consumer genetic testing
Many patients ask whether services that provide “health risk” reports can help. Here’s the grounded answer:
Direct-to-consumer results may eventually incorporate more endometriosis-related signals, but today they’re unlikely to change your care plan, because:
- The effect sizes seen here are small (risk nudges, not risk determinants).
- These signatures haven’t been validated as a clinical diagnostic tool with the measures that matter (sensitivity, specificity, real-world accuracy).
- Most people carry some risk variants—having them doesn’t mean you’ll develop endometriosis, and not having them doesn’t mean you won’t.
If you choose to do genetic testing anyway, please understand that you are doing it for curiosity—not as your pathway to better or faster diagnosis or treatment.
Practical takeaways: how to use this information in real life
You deserve care that treats symptoms seriously now, not someday when genetics catches up. Use this research as a conversation tool—mainly to support the idea that endometriosis is complex and can involve inflammation, scarring, and nerve pain. These all have different, but potentially overlapping, molecular drivers.
Here are focused questions you can bring to your clinician (especially if symptoms persist despite first-line treatment):
- “Given my symptoms, do you think my pain has a neuropathic component—and if so, what are our treatment options beyond hormones?”
- “Do my symptoms suggest significant fibrosis/adhesions—and should I be evaluated by a surgeon with high-volume endometriosis expertise?”
- “If hormones haven’t helped enough, what’s our plan B for pain sensitization (pelvic floor PT, nerve pain medications, multidisciplinary pain care)?”
- “How are we addressing bowel/bladder symptoms—and when should we involve GI/urology?”
- “If I have suspected or confirmed adenomyosis, how does that change the plan?”
(That’s not because this paper tells you exactly what to do. It’s because it reinforces that different biological drivers can matter—and your plan should be individualized. IF these questions are met with a blank stare, you need another consultant.)
Reality check: what we still don’t know
This kind of research is promising, but it’s early.
- Association isn’t causation. These genetic patterns don’t prove what causes endometriosis or which pathway is driving your pain.
- Prediction is limited. The strongest individual signal reported still only modestly increases odds; it’s not diagnostic.
- Population differences matter. Findings from one ancestry group don’t always transfer cleanly to others, and “reproducibility” can look different depending on cohort size and how endometriosis was defined.
- Endometriosis vs adenomyosis vs overlap remains a major clinical reality—many patients have both, and research definitions don’t always match real-life complexity.
The most helpful way to hold this information is: genetics is slowly mapping the terrain, which may eventually improve targeted molecular treatments and shorten diagnosis delays. For today, your best path to relief right now is still evidence-based symptom management, access to experienced care, and a plan that takes your quality of life seriously. Consider getting an opinion from an endometriosis expert that is up-to-date as well as keeping up with future developments.
References
Sardell, Das, Møller, Sanna, Chocian, Taylor, Malinowski, Stubberfield, Rochlin, Gardner. Identification and Validation of Novel Combinatorial Genetic Risk Factors for Endometriosis across Multiple UK and US Patient Cohorts. medRxiv. 2025. PMCID: PMC12363715. PMID: 40832379.
Quick Answers
How do I make the most of a short endometriosis appointment?
Go in with a one-page snapshot of your story so the limited time is spent on decision-making, not backtracking. The most helpful snapshot includes: your top 2–3 symptoms, the pattern (cyclical vs daily, triggers, where pain starts and spreads), what you’ve already tried and what happened, and what your symptoms keep you from doing (work, school, intimacy, exercise). If you have a history of “normal” scans, bring that too—because imaging can miss endometriosis, and the pattern of symptoms and prior response to treatment still matters.
Bring the right records if you have them—especially operative reports, pathology, and imaging reports (and ideally the actual images). Then decide your goal for the visit: diagnostic clarity, a plan to evaluate look-alike or coexisting conditions, or a clear surgical discussion (whether surgery is likely to help, anticipated scope, and what recovery may involve). If you want to make the appointment count even more, reach out to our team ahead of time so we can review what you’ve already done and tell you exactly what information would be most useful for a focused, productive conversation.
What questions should I ask an endometriosis specialist?
Come in focused on how your surgeon thinks and how your care will be mapped out. Helpful questions include: based on my symptoms and records, what diagnoses are you considering (endometriosis, adenomyosis, and common look‑alikes), and what makes you lean one way or another? Ask what additional records or imaging would meaningfully change the plan, and whether your imaging will be interpreted with endometriosis mapping in mind—not just a “normal/abnormal” read.
If surgery is on the table, ask for specifics about technique and scope: do you primarily perform excision (rather than superficial burning/ablation), and how do you confirm what was removed (photos, operative report detail, pathology)? Ask what areas you expect could be involved in your case (ovaries, bowel, bladder/ureters, diaphragm) and whether a multidisciplinary team is planned if those organs may be affected. It’s also reasonable to ask how they define surgical “success” for your goals—pain relief, bowel/bladder function, fertility—and how outcomes and recurrence/persistent symptoms are handled.
Finally, ask how the care process works from start to finish: what the pre‑op workup includes, what recovery typically looks like for the anticipated complexity, and how follow‑up is structured if symptoms don’t resolve fully. In our practice, we review records purposefully before meeting so the conversation is productive and realistic, and we’ll be direct about whether surgery seems likely to help or whether another path makes more sense. If you’d like, you can reach out to schedule a consultation and we’ll tell you exactly what to send first so we can make your visit worth your time.
Can endometriosis and interstitial cystitis happen together?
Yes—endometriosis and interstitial cystitis/bladder pain syndrome (IC/BPS) can occur together, and that overlap is one reason bladder symptoms can be so frustrating and persistent. Endometriosis can cause urinary urgency, frequency, burning, or bladder-adjacent pelvic pressure, but those same symptoms can also come from IC/BPS. Having one diagnosis doesn’t “rule out” the other, and when both are present, treating only endometriosis may not fully relieve bladder-driven pain.
A key part is sorting out what’s actually driving your symptoms: bladder endometriosis (lesions involving the bladder wall) is different from IC/BPS, even though they can feel similar. Bladder endometriosis often has a cyclical pattern around periods (though not always), while IC/BPS is typically pain/pressure that feels related to bladder filling and may improve after urinating, with symptoms persisting over time despite negative urine cultures. Our team looks at the whole picture—gynecologic, urinary, pelvic floor, and nervous system pain pathways—so we can build a plan that matches your specific symptom pattern rather than forcing everything into a single label.
If you’re dealing with ongoing urinary urgency/frequency, burning, or bladder pain—especially if prior endometriosis treatments haven’t helped as expected—reach out to schedule a consultation. We can help you determine whether this looks more like urinary tract endometriosis, IC/BPS, or a combination, and what next-step evaluation and treatment options make the most sense for you.
Does endometriosis stage predict pain severity?
Not reliably. The ASRM stages (I–IV) mainly describe what’s seen at surgery—location, amount of disease, scarring, and adhesions—not how your nervous system experiences pain. That’s why someone can have “low-stage” endometriosis with debilitating symptoms, while another person with more extensive disease reports surprisingly little pain.
Pain tends to correlate more with where lesions are, whether deeper structures are involved (like bowel, bladder, ureters, or pelvic nerves), and how much inflammation, pelvic floor guarding, and pain sensitization have developed over time. In our practice, we focus less on the stage number and more on your specific symptom pattern (period pain, pain with sex, bowel/bladder symptoms, cyclical flares, leg or diaphragmatic pain), paired with expert imaging when appropriate, to understand what’s driving your pain.
If you’ve been told your pain “shouldn’t be that bad” because of a stage label, you’re not alone—and you’re not imagining it. Exploring endometriosis subtypes, coexisting conditions (like adenomyosis), and pain mechanisms often explains the mismatch and opens the door to more targeted treatment options, including excision when indicated. If you’d like, you can reach out to schedule a consultation so our team can review your history and help map symptoms to likely sources.
What should I tell ER staff about my endometriosis?
If you’re in the ER with pelvic or abdominal pain and you have endometriosis (or strong suspicion of it), lead with the facts that help them triage safely: your diagnosis status (surgically confirmed vs suspected), any prior operative and pathology findings, and whether you’ve had complications like bowel, bladder, appendix, or diaphragm/thoracic involvement. Tell them what today’s pain is doing differently from your baseline—sudden onset, one-sided or right-lower-quadrant pain, fever, vomiting, fainting, heavy bleeding, chest/shoulder pain, or shortness of breath—and whether it seems cyclical or tied to your period. ER teams are trained to rule out emergencies first, so describing “what changed” and “what worries you most” helps them move faster and document the right differentials.
It also helps to be very specific about your symptom pattern and functional impact rather than just saying “endo flare.” For example: pain with urination or bladder filling, pain with bowel movements, constipation/diarrhea flares, rectal pressure, deep pain with sex, or pain that radiates to the back/leg—especially if those symptoms have a clear cycle pattern. If you have records, bring or show the most useful ones: operative reports, pathology reports, and recent imaging reports (and images if you have them). Those details can prevent your history from being minimized just because a CT or ultrasound looks “normal.”
After the urgent issue is addressed, many patients still need a clearer plan for the underlying driver of recurrent ER-level pain. Our team can review your records, make your history “clinically legible,” and discuss whether specialized evaluation and excision surgery may be appropriate—especially if you’ve been dismissed, have persistent symptoms despite prior treatment, or suspect deeper or multi-organ disease.

